Pyruvate Carboxylase Deficiency Disease: Clinical Trials

1 trial for Pyruvate Carboxylase Deficiency Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 no longer available. .

Follow Pyruvate Carboxylase Deficiency Disease: new trials by email Literature Review of Pyruvate Carboxylase Deficiency Disease trials Research Report on Pyruvate Carboxylase Deficiency Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
triheptanoin - Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2)
No longer availableJerry Vockley, MD, PhD2021-12-10

Narrower conditions

Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)  ·  Barth Syndrome (1)  ·  Trifunctional Protein Deficiency With Myopathy And Neuropathy (1)  ·  VLCAD deficiency (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heart Defects, Congenital (1)  ·  Heart Diseases (1)  ·  Lipid Metabolism Disorders (1)

Interventions

triheptanoin (1)

Sponsors

Jerry Vockley, MD, PhD (1)

Countries

United States (1)

Top investigators

Jerry Vockley, MD, PhD (1)